Vanhees L, Fagard R, Amery A
Department of Pathophysiology, University of Leuven, Belgium.
Eur J Appl Physiol Occup Physiol. 1988;58(1-2):87-91. doi: 10.1007/BF00636608.
The effect of verapamil (240 mg) on exercise capacity was studied during a short graded and a single-level endurance exercise test in 12 normal volunteers; it was compared to the effects of atenolol (100 mg x day-1). Intake of verapamil, atenolol and placebo, administered according to a randomized, double-blind cross-over design, was started 3 days before the exercise tests. Compared to placebo, verapamil did not affect peak oxygen uptake in the graded test or exercise duration in the endurance test. Heart rate, systolic blood pressure, rating of perceived exertion and respiratory data at submaximal and peak exercise were unaffected in either test. On the other hand atenolol reduced maximal oxygen uptake by 5% (p less than 0.001) and endurance exercise duration by 17% (p less than 0.05). Besides marked decreases in heart rate and systolic blood pressure during the two types of exercise, atenolol also reduced oxygen uptake at submaximal exercise levels and it increased the rating of perceived exertion (p less than 0.05), the latter only during the endurance exercise test.
在12名正常志愿者的短时间分级运动试验和单级耐力运动试验中,研究了维拉帕米(240毫克)对运动能力的影响;并将其与阿替洛尔(100毫克/天)的作用进行了比较。根据随机、双盲交叉设计,在运动试验前3天开始服用维拉帕米、阿替洛尔和安慰剂。与安慰剂相比,维拉帕米在分级试验中不影响峰值摄氧量,在耐力试验中不影响运动持续时间。在任一试验中,次最大运动和峰值运动时的心率、收缩压、主观用力评分和呼吸数据均未受影响。另一方面,阿替洛尔使最大摄氧量降低了5%(p<0.001),耐力运动持续时间降低了17%(p<0.05)。除了在两种运动过程中心率和收缩压显著降低外,阿替洛尔还降低了次最大运动水平时的摄氧量,并增加了主观用力评分(p<0.05),后者仅在耐力运动试验期间出现。